Table 1.
Summary statistics of the patients’ clinical characteristics
| Clinical Characteristic | Summary Statistics | |
|---|---|---|
| Age | Median | 64 years |
| Range | 46–71 years | |
| PSA (ng/mL) | Median | 0.21 |
| IQR | 0.15–0.36 | |
| PSA doubling time (months) | Median | 6.5 |
| Range | 0–37.9 | |
| Radical Prostatectomy | Gleason Score | |
| 3+3 | 8 (6%) | |
| 3+ | 53 (37%) | |
| 4+ | 51 (36%) | |
| ≥4+4 | 28 (20%) | |
| N/A | 2 (1%) | |
| Pathologic stage | 99 (70%) | |
| ≤pT2 | 43 (30%) | |
| pT3a | 71 (50%) | |
| ≥pT3b | 28 (20%) | |
| Surgical Margins | ||
| Negative | 79 (56%) | |
| Positive | 61 (43%) | |
| N/A | 2 (1%) | |
| Interval prostatectomy to Imaging (days) | Median | 933 days |
| Range | 59–5572 days | |
PSA: prostate specific antigen; IQR: inter-quantile range